Cargando…

The clinical course and prognostic factors of severe COVID-19 in Wuhan, China: A retrospective case-control study

With the surge of newly diagnosed and severe cases of coronavirus disease 2019 (COVID-19), the death toll is mounting, this study is aimed to explore the prognostic factors of severe COVID-19. This retrospective study included 122 inpatients diagnosed with COVID-19 from January 13 to February 25, 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jiacheng, Tu, Chao, Zhu, Muxin, Wang, Jianwen, Yang, Chongtu, Liu, Wei, Xiong, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909135/
https://www.ncbi.nlm.nih.gov/pubmed/33663044
http://dx.doi.org/10.1097/MD.0000000000023996
_version_ 1783655864872206336
author Liu, Jiacheng
Tu, Chao
Zhu, Muxin
Wang, Jianwen
Yang, Chongtu
Liu, Wei
Xiong, Bin
author_facet Liu, Jiacheng
Tu, Chao
Zhu, Muxin
Wang, Jianwen
Yang, Chongtu
Liu, Wei
Xiong, Bin
author_sort Liu, Jiacheng
collection PubMed
description With the surge of newly diagnosed and severe cases of coronavirus disease 2019 (COVID-19), the death toll is mounting, this study is aimed to explore the prognostic factors of severe COVID-19. This retrospective study included 122 inpatients diagnosed with COVID-19 from January 13 to February 25, 2020. Univariate and multivariate analysis were used to identity the risk factors, receiver operating characteristics curve (ROC) analysis was used for risk stratification. The baseline neutrophil-to-lymphocyte ratio (NLR) (OR = 1.171, 95%CI = 1.049–1.306, P = .005) and Lactate dehydrogenase (LDH) (OR = 1.007, 95%CI = 1.002–1.011, P = .004) were identified as the independent risk factors for severe COVID-19 conditions, and the NLR-LDH grading system was developed to perform risk stratification. The baseline C-reactive protein (CRP) (OR = 1.019, 95%CI = 1.004–1.306, P = .016) and B-type natriuretic peptide (BNP) (OR = 1.018, 95%CI = 1.004–1.035, P = .007) were identified as the independent predictors for disease progression of severe patients. Accordingly, The NLR-LDH grading system was a useful prognostic tool for the early detection of severe COVID-19. And in the severe patients, CRP and BNP seemed to be helpful for predicting the disease progression or death.
format Online
Article
Text
id pubmed-7909135
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-79091352021-03-01 The clinical course and prognostic factors of severe COVID-19 in Wuhan, China: A retrospective case-control study Liu, Jiacheng Tu, Chao Zhu, Muxin Wang, Jianwen Yang, Chongtu Liu, Wei Xiong, Bin Medicine (Baltimore) 4900 With the surge of newly diagnosed and severe cases of coronavirus disease 2019 (COVID-19), the death toll is mounting, this study is aimed to explore the prognostic factors of severe COVID-19. This retrospective study included 122 inpatients diagnosed with COVID-19 from January 13 to February 25, 2020. Univariate and multivariate analysis were used to identity the risk factors, receiver operating characteristics curve (ROC) analysis was used for risk stratification. The baseline neutrophil-to-lymphocyte ratio (NLR) (OR = 1.171, 95%CI = 1.049–1.306, P = .005) and Lactate dehydrogenase (LDH) (OR = 1.007, 95%CI = 1.002–1.011, P = .004) were identified as the independent risk factors for severe COVID-19 conditions, and the NLR-LDH grading system was developed to perform risk stratification. The baseline C-reactive protein (CRP) (OR = 1.019, 95%CI = 1.004–1.306, P = .016) and B-type natriuretic peptide (BNP) (OR = 1.018, 95%CI = 1.004–1.035, P = .007) were identified as the independent predictors for disease progression of severe patients. Accordingly, The NLR-LDH grading system was a useful prognostic tool for the early detection of severe COVID-19. And in the severe patients, CRP and BNP seemed to be helpful for predicting the disease progression or death. Lippincott Williams & Wilkins 2021-02-26 /pmc/articles/PMC7909135/ /pubmed/33663044 http://dx.doi.org/10.1097/MD.0000000000023996 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle 4900
Liu, Jiacheng
Tu, Chao
Zhu, Muxin
Wang, Jianwen
Yang, Chongtu
Liu, Wei
Xiong, Bin
The clinical course and prognostic factors of severe COVID-19 in Wuhan, China: A retrospective case-control study
title The clinical course and prognostic factors of severe COVID-19 in Wuhan, China: A retrospective case-control study
title_full The clinical course and prognostic factors of severe COVID-19 in Wuhan, China: A retrospective case-control study
title_fullStr The clinical course and prognostic factors of severe COVID-19 in Wuhan, China: A retrospective case-control study
title_full_unstemmed The clinical course and prognostic factors of severe COVID-19 in Wuhan, China: A retrospective case-control study
title_short The clinical course and prognostic factors of severe COVID-19 in Wuhan, China: A retrospective case-control study
title_sort clinical course and prognostic factors of severe covid-19 in wuhan, china: a retrospective case-control study
topic 4900
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909135/
https://www.ncbi.nlm.nih.gov/pubmed/33663044
http://dx.doi.org/10.1097/MD.0000000000023996
work_keys_str_mv AT liujiacheng theclinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy
AT tuchao theclinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy
AT zhumuxin theclinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy
AT wangjianwen theclinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy
AT yangchongtu theclinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy
AT liuwei theclinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy
AT xiongbin theclinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy
AT liujiacheng clinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy
AT tuchao clinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy
AT zhumuxin clinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy
AT wangjianwen clinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy
AT yangchongtu clinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy
AT liuwei clinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy
AT xiongbin clinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy